Mike Doustdar

Novo Nordisk expands GLP-1 pipeline amid patent and M&A head

106 clusters · 512 sources · last updated about 5 hours ago

Latest: Novo Nordisk shares fall despite ambitious 2030 drug pipeline targets

Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima

GLP-1 drugs: clinical trends, safety, and market shifts

259 clusters · 927 sources · last updated about 6 hours ago

Latest: Medical experts warn of weight regain risks for GLP-1 users

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

Bayer strategic growth and financial targets

2 clusters · 8 sources · last updated 2 days ago

Latest: Novo Nordisk to present strategic goals at London Capital Markets Day

Bayer is pursuing a strategic framework focused on translating research and innovation into financial growth. Its Crop Science division has set targets for 2029, aiming for over €3 billion in free operating cash flow and

Novo Nordisk leadership and cultural restructuring

3 clusters · 9 sources · last updated 4 days ago

Latest: Novo Nordisk faces media criticism over rebranding communication

Novo Nordisk has undergone significant leadership and structural changes following a period of market instability and competition. Under CEO Mike Doustdar, the company faced internal friction after he urged employees to

Novo Nordisk AI drug discovery partnerships

2 clusters · 13 sources · last updated 5 days ago

Latest: Novo Nordisk partners with Anthropic to accelerate drug discovery via AI

Novo Nordisk has initiated several strategic partnerships to integrate artificial intelligence into its drug discovery and research workflows. In late August 2026, the company partnered with Amazon Web Services (AWS) to

Novo Nordisk corporate rebranding and health initiatives

2 clusters · 21 sources · last updated 8 days ago

Latest: Novo Nordisk rebrands to Novo with new logo and slogan

Novo Nordisk has initiated several strategic moves regarding its brand identity and public health engagement. The company entered a partnership with the Norwegian football club Bodø/Glimt to promote physical activity and

Novo Nordisk AI integration and market developments

5 clusters · 14 sources · last updated 13 days ago

Latest: Novo Nordisk executes 9 billion DKK share buyback amid pipeline shifts

Novo Nordisk continues to integrate artificial intelligence into its pharmaceutical development through strategic partnerships. Following its collaboration with H1, the company established an AI innovation center and co-